News & Media

News & Media2020-11-17T08:39:01+09:30

Carina Biotech licenses German technology to create highly efficient CAR-T cells targeting hard-to-treat cancers

December 15th, 2021|

Carina Biotech has entered a license agreement with Bayerische Patentallianz (BayPAT) to the CXCR6-transduced CAR-T cell technology developed at the

Manufacture of Carina’s LGR5 CAR-T has begun with CellVec contracted to produce GMP-grade lentivirus constructs

November 9th, 2021|

Singapore-based CellVec will manufacture clinical-grade lentivirus – the first critical step in making LGR5 CAR-T cells for a first-in-human clinical


If you have a news item related to this field of medical & scientific research that you feel would be of interest to us, please contact us.

Go to Top